tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD

Compare Opus Genetics (IRD) vs. Competitors

Compare
1,251 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Opus Genetics
$2.31
$159.31M
-1.34
108.11%
9 Buy
0 Hold
0 Sell
Strong Buy
Ovid Therapeutics
$1.56
$203.09M
-3.05
122.86%
8 Buy
0 Hold
0 Sell
Strong Buy
Shattuck Labs
$3.87
$244.89M
-3.79
209.60%
3 Buy
2 Hold
0 Sell
Moderate Buy
Inhibikase Therapeutics
$1.50
$181.90M
-2.63
-21.87%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$21.54
$184.67M
-0.99
78.50%
3 Buy
0 Hold
0 Sell
Strong Buy
Biomea Fusion
$1.12
$79.19M
-0.47
-73.65%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IRD
Opus Genetics
2.31
1.23
113.89%
OVID
Ovid Therapeutics
1.56
0.90
136.36%
STTK
Shattuck Labs
3.87
2.59
202.34%
IKT
Inhibikase Therapeutics
1.50
-0.66
-30.56%
SRZN
Surrozen
21.55
10.64
97.48%
BMEA
Biomea Fusion
1.12
-2.81
-71.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts